Ahmad Tea to double American sales

By Nell Walker
Share

Ahmad Tea is aiming to double its US sales.

Ahmad Tea is the global leader in loose leaf tea, having begun in Southampton, UK, in 1986. The family-owned business has enjoyed enormous success for the past 30 years, swiftly expanding into the US, Russia, Iran, and Iraq, with international sales accounting for over 95 percent of the business.

The company now plans to double its US sale from $8 million to $16 million by 2018. It has enjoyed 15 percent growth year-on-year across the United States thanks to its dedication to product development and manufacturing innovation. Ahmed Tea holds around two percent of the global market share and has over 1,000 employees worldwide.

Building on global retail sales of $300 million per annum, Ahmad Tea will be further enhancing its operations through state-of-the-art manufacturing, sales and distribution expansion, and product development to achieve its latest goals.

Ahmad Tea products are already stocked in some of the biggest US food retailers, including Whole Foods and Giant Food Stores, as well as in many independent retail chains. This will only increase as the company makes a larger mark on the nation. 

 

Follow @BizReviewUSA and @NellWalkerMG

Read the July issue of Business Review USA & Canada here

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy